Cargando…
The Role of GPR109a Signaling in Niacin Induced Effects on Fed and Fasted Hepatic Metabolism
Signaling through GPR109a, the putative receptor for the endogenous ligand β-OH butyrate, inhibits adipose tissue lipolysis. Niacin, an anti-atherosclerotic drug that can induce insulin resistance, activates GPR109a at nM concentrations. GPR109a is not essential for niacin to improve serum lipid pro...
Autores principales: | Geisler, Caroline E., Miller, Kendra E., Ghimire, Susma, Renquist, Benjamin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069761/ https://www.ncbi.nlm.nih.gov/pubmed/33924461 http://dx.doi.org/10.3390/ijms22084001 |
Ejemplares similares
-
A critical role of hepatic GABA in the metabolic dysfunction and hyperphagia of obesity
por: Geisler, Caroline E., et al.
Publicado: (2021) -
Structural and Energetic Insights Into the Interaction of Niacin With the GPR109A Receptor
por: Adepu, Kiran Kumar, et al.
Publicado: (2021) -
Niacin Ameliorates Neuro-Inflammation in Parkinson’s Disease via GPR109A
por: Giri, Banabihari, et al.
Publicado: (2019) -
Niacin Alleviates Dairy Cow Mastitis by Regulating the GPR109A/AMPK/NRF2 Signaling Pathway
por: Guo, Wenjin, et al.
Publicado: (2020) -
Low-dose niacin supplementation modulates GPR109A, niacin index and ameliorates Parkinson’s disease symptoms without side effects
por: Wakade, Chandramohan, et al.
Publicado: (2015)